Drug Use Investigation For Hiv Infection Patients Of Maraviroc (Regulatory Post Marketing Commitment Plan).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors ViiV Healthcare
- 26 Jan 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 16 Jan 2014 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov record.
- 22 Nov 2013 Planned end date changed from 1 Mar 2018 to 1 Mar 2019 as reported by ClinicalTrials.gov.